Avicanna Inc.
OTC: AVCNF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Aras Azadian Mba
- Employees
- 87
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- $11.1M
- Website
- https://www.avicanna.com
Loading AVCNF…
Loading profile data…Frequently asked questions about AVCNF
What does Avicanna Inc. (AVCNF) do?
Avicanna Inc. is a biopharmaceutical company already in its commercial phase, dedicated to the research and development of scientifically-backed products for global consumer health and pharmaceutical sectors. It maintains partnerships with Canadian academic and medical institutions. Its scientific approach, encompassing robust R&D and clinical d...
Where does AVCNF trade?
Avicanna Inc. (AVCNF) trades on the Other OTC.
What sector is AVCNF in?
Avicanna Inc. (AVCNF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Avicanna Inc.?
Aras Azadian Mba is the chief executive officer of Avicanna Inc. (AVCNF).
Where is Avicanna Inc. headquartered?
Avicanna Inc. is headquartered in Canada.
Does AVCNF pay a dividend?
Avicanna Inc. (AVCNF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AVCNF go public?
Avicanna Inc. (AVCNF) completed its initial public offering in 2021.